ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1817

The Clinical Burden Of Generalized Osteoarthritis Represented By Activity Limitations and Health Related Quality Of Life: A Cross-Sectional Study

Nienke Cuperus1, Thea Vliet Vlieland2, Elien Mahler1, Clarinda Kersten1, Thomas Hoogeboom3 and Els van den Ende1, 1Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Department of Orthopaedics, University Medical Center Leiden, Leiden, Netherlands, 3Department of Epidemiology, CAPHRI school for public health and primary care, CCTR centre for Care Technology Research, Maastricht University, Maastricht, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: activities of daily living (ADL), Osteoarthritis, patient outcomes and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rehabilitation Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose: A growing body of evidence shows that generalized osteoarthritis (GOA) is fairly common, however research and clinical practice recommendations are mainly focused on a specific localization of osteoarthritis (OA). As a consequence the clinical burden of GOA is largely unknown. More insight into the clinical burden of GOA is needed in order to improve its management and to develop treatment tailored to the patients’ needs and problems. Therefore the aim of this study was to determine the clinical burden of GOA in terms of activity limitations and health related quality of life (HRQoL).

Methods: Baseline data from a randomized controlled trial (RCT) comparing two non-pharmacological treatment programmes for patients with GOA were used. GOA was defined as having musculoskeletal complaints in >2 joint groups and having >1 objective signs of OA in >1 joint. In addition, patients had to be limited in performing daily activities (HAQ-DI score > 0.5). Patients clinically diagnosed with GOA by a rheumatologist and referred to multidisciplinary treatment completed self-reported questionnaires to assess socio-demographics, joint involvement (self-report and objective), activity limitations (HAQ-DI) and HRQoL (SF-36 physical (PCS) and mental component summary (MCS) norm based scores). Patients were asked to report the three most important activity limitations due to GOA and to rate its severity on a visual analogue scale. Reported activity limitations were linked to the International Classification of Functioning, Disability and Health (ICF) using established linking rules. 

Results:  In total, 147 patients (85% female) participated in this study with a mean (SD) age of 60 (8) years. Hundred-fifteen patients (78%) reported musculoskeletal complaints in ≥ 4 joint areas. Self-reported and objective signs of OA were most common in the hands (n = 125; 85%) and knees (n = 121; 82%). Patients with GOA were moderately to severely limited in performing daily activities reflected by a mean (SD) HAQ-DI score of 1.27 (0.50). “Much difficulty” with activities such as shopping or doing chores were reported by more than half of the patients. Patients with GOA experience a markedly reduced HRQoL on the physical domain reflected by a mean (SD) PCS score of 32 (8), which is comparable with the impact of Rheumatoid Arthritis on HRQoL. Activities concerning mobility and domestic life were most frequently reported as being important activity limitations, in particular walking (Table 1).

Conclusion:  The results of this study suggest a high clinical burden at least in selected patients with GOA in terms of activity limitations and HRQoL. According to the results it is conceivable that non-pharmacological treatment targets for patients with GOA may focus especially on the physical domain of HRQoL and on mobility limitations (walking in particular) as these activities are the most important for patients.

 

Table 1. The ten most frequently reported, self-perceived activity problems with corresponding ICF codes and corresponding mean (SD) severity scores in 147 patients with Generalized Osteoarthritis (GOA).

ICF code

Activity

N (%)

Mean (SD) severity (0-10)

d450

Walking

71 (48)

6.7 (2.1)

d415

Maintaining a body position

46 (31)

6.4 (2.4)

d410

Changing basic body position

41 (28)

7.1 (1.8)

d640

Doing housework

35 (24)

6.9 (1.7)

d455

Moving around (climbing stairs)

35 (24)

6.5 (2.0)

d430

Lifting and carrying objects

30 (20)

6.1 (2.0)

d440

Fine hand use

25 (17)

6.5 (2.0)

d650

Caring for household objects

24 (16)

7.3 (1.7)

d920

Recreation and leisure

22 (15)

6.1 (2.2)

d475

Driving

20 (14)

6.2 (2.9)


Disclosure:

N. Cuperus,
None;

T. Vliet Vlieland,
None;

E. Mahler,
None;

C. Kersten,
None;

T. Hoogeboom,
None;

E. van den Ende,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-clinical-burden-of-generalized-osteoarthritis-represented-by-activity-limitations-and-health-related-quality-of-life-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology